Loading clinical trials...
Loading clinical trials...
Everolimus (Afinitor) in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
Conditions
Interventions
Everolimus
Locations
3
Russia
Tatarstan Regional Cancer Center
Kazan', Tatarstan Republic, Russia
Altai Regional Cancer Center
Barnaul, Russia
N.N. Blokhin Russian Cancer Research Center
Moscow, Russia
Start Date
November 1, 2011
Primary Completion Date
April 1, 2013
Completion Date
October 1, 2013
Last Updated
February 6, 2014
NCT06391099
NCT07227415
NCT06835972
NCT07175480
NCT05700461
NCT05122546
Lead Sponsor
Kidney Cancer Research Bureau
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions